BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1537074)

  • 21. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
    Gomes CM; van Paassen H; Romeo S; Welling MM; Feitsma RI; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels E; Cleton-Jansen AM
    Nucl Med Biol; 2006 Oct; 33(7):831-40. PubMed ID: 17045162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a human multidrug resistance gene in ovarian carcinomas.
    Bourhis J; Goldstein LJ; Riou G; Pastan I; Gottesman MM; Bénard J
    Cancer Res; 1989 Sep; 49(18):5062-5. PubMed ID: 2766278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft.
    Abe Y; Yamazaki H; Oshika Y; Suto R; Tsugu A; Ota E; Satoh H; Ohnishi Y; Yanagawa T; Ueyama Y; Tamaoki N; Nakamura M
    Anticancer Res; 1996; 16(2):729-34. PubMed ID: 8687121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of MDR1-gene expression by antineoplastic agents in ovarian cancer cell lines.
    Schöndorf T; Kurbacher CM; Göhring UJ; Benz C; Becker M; Sartorius J; Kolhagen H; Mallman P; Neumann R
    Anticancer Res; 2002; 22(4):2199-203. PubMed ID: 12174904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
    He Y; Zhang J; Zhang J; Yuan Y
    Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.
    Shen LZ; Hua YB; Yu XM; Xu Q; Chen T; Wang JH; Wu WX
    World J Gastroenterol; 2005 Feb; 11(7):1060-4. PubMed ID: 15742416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
    Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
    Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L; Lang J; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
    Bénard J; Da Silva J; Teyssier JR; Riou G
    Int J Cancer; 1989 Mar; 43(3):471-7. PubMed ID: 2925277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
    Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
    Naito S; Koike K; Ono M; Machida T; Tasaka S; Kiue A; Koga H; Kumazawa J
    Oncol Res; 1998; 10(3):123-32. PubMed ID: 9700723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.